KM TRANSDERM

KM Transderm Ltd. has developed adhesive polymer technology for transdermal formulations based on Kaneka's traditional core technology, polymer compounding. We can control the adhesive performance quite flexibly with this technology. Utilizing strong network with leading pharmaceutical companies, KM Transderm pursues patient-friendly medical products which can contribute to improve the QOL of patients, and that is required at medical fields... Through our global network involving pharmaceutical companies and other entities, we understand the requirements of physicians and patients, such as the QOL needs, and develop drug formulations by combining our proprietary technologies. While developing medical products by ourselves until proof-of-concept (superiority of medical products) is demonstrated, we aim to form partnerships with pharmaceutical companies (development and sales partners). To help pharmaceutical companies develop new medical products, we also offer business solutions to..

Also known as: KM Transderm Ltd

Primary location: Osaka Japan